Efficient ex vivo induction of T cells with potent anti-tumor activity by protein antigen encapsulated in nanoparticles (Q39161562)

9 September 2017

Efficient ex vivo induction of T cells with potent anti-tumor activity by protein antigen encapsulated in nanoparticles (English)

1 reference

9 September 2017

0 references

5

Wim Jiskoot

1 reference

9 September 2017

Sjoerd H van der Burg

6

object named as

Sjoerd H van der Burg

1 reference

9 September 2017

Rodney A Rosalia

1

1 reference

9 September 2017

Ana Luisa Silva

2

1 reference

9 September 2017

Marcel Camps

3

1 reference

9 September 2017

Ahmed Allam

4

1 reference

9 September 2017

Ferry Ossendorp

7

1 reference

9 September 2017

Jaap Oostendorp

8

1 reference

9 September 2017

24 April 2013

1 reference

Cancer Immunology, Immunotherapy

9 September 2017

1 reference

9 September 2017

62

1 reference

9 September 2017

1161-1173

1 reference

9 September 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-013-1411-0

9 September 2017

0 references

cites work

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Cancer immunotherapy by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Tumor antigen presentation by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

IL-2 is required for the activation of memory CD8+ T cells via antigen cross-presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Helper activity is required for the in vivo generation of cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

MAGE-A family: attractive targets for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Comparing pooled peptides with intact protein for accessing cross-presentation pathways for protective CD8+ and CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Ovalbumin peptide encapsulated in poly(d,l lactic-co-glycolic acid) microspheres is capable of inducing a T helper type 1 immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Engineered PLGA nanoparticles: an emerging delivery tool in cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Effect of poly(lactic-co-glycolic acid) contact on maturation of murine bone marrow-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

A comprehensive platform for ex vivo T-cell expansion based on biodegradable polymeric artificial antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Cancer immunotherapy via dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Decisions about dendritic cells: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Adoptive cell therapy for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Adoptive immunotherapy for cancer: harnessing the T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

LacZ inducible, antigen/MHC-specific T cell hybrids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Introduction of soluble protein into the class I pathway of antigen processing and presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Tumor eradication by immunotherapy with biodegradable PLGA microspheres--an alternative to incomplete Freund's adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Cytokines and T-cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Role of CD27/CD70 pathway of activation in immunity and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

T cell costimulation by TNFR superfamily (TNFRSF)4 and TNFRSF25 in the context of vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Interleukin-12 and the regulation of innate resistance and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Artificial antigen-presenting cells for use in adoptive immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Adoptive immunotherapy for cancer: building on success

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naïve repertoire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Incubation of antigen-sensitized T lymphocytes activated with bryostatin 1 + ionomycin in IL-7 + IL-15 increases yield of cells capable of inducing regression of melanoma metastases compared to culture in IL-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Activation-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Activation-induced cell death in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Adoptive transfer of tumor-specific Tc17 effector T cells controls the growth of B16 melanoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Human papilloma virus specific T cells infiltrating cervical cancer and draining lymph nodes show remarkably frequent use of HLA-DQ and -DP as a restriction element.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Differential effects of agarose and poly(lactic-co-glycolic acid) on dendritic cell maturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Microencapsulation of inorganic nanocrystals into PLGA microsphere vaccines enables their intracellular localization in dendritic cells by electron and fluorescence microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Human tumor-specific T lymphocytes: does function matter more than number?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Biodegradable polymers for use in surgery—polyglycolic/poly(actic acid) homo- and copolymers: 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

Co-stimulatory molecules in and beyond co-stimulation - tipping the balance in atherosclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1411-0

10.1007/S00262-013-1411-0

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference